Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development

Stock Information for Dyadic International Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Dyadic International Inc.

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Sidoti Events, LLC's May Micro-Cap Virtual Conference
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.